Literature DB >> 10100020

A sheep model for continuous intrathecal infusion of test substances.

S J Hassenbusch1, W C Satterfield, T L Gradert.   

Abstract

Pharmaceutical research and new drug development rely extensively on animal research. The development of novel agents for intrathecal administration requires preclinical studies of toxic effects in an animal model. We have developed a nonrodent animal model for this purpose. Our sheep model: 1 Is an animal whose neural axis is similar to the human 2 Allows for the percutaneous placement of intrathecal catheters 3 Has minimal possibilities of infection because the infusion system is totally implanted 4 Provides continuous infusion of the test agent 5 Generates behavioral, motor, neurological and histopathological information so that safety guidelines can be established prior to preclinical studies.

Entities:  

Mesh:

Year:  1999        PMID: 10100020     DOI: 10.1177/096032719901800204

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  2 in total

1.  A large animal neuropathic pain model in sheep: a strategy for improving the predictability of preclinical models for therapeutic development.

Authors:  Denise Wilkes; Guangwen Li; Carmina F Angeles; Joel T Patterson; Li-Yen Mae Huang
Journal:  J Pain Res       Date:  2012-10-25       Impact factor: 3.133

2.  Identification of key genes and pathways involved in response to pain in goat and sheep by transcriptome sequencing.

Authors:  Xiuling Deng; Dong Wang; Shenyuan Wang; Haisheng Wang; Huanmin Zhou
Journal:  Biol Res       Date:  2018-08-17       Impact factor: 5.612

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.